Alan B. Lancz & Associates, Inc. Pfizer Inc Transaction History
Alan B. Lancz & Associates, Inc.
- $108 Million
- Q3 2024
A detailed history of Alan B. Lancz & Associates, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Alan B. Lancz & Associates, Inc. holds 18,055 shares of PFE stock, worth $482,429. This represents 0.48% of its overall portfolio holdings.
Number of Shares
18,055
Previous 18,055
-0.0%
Holding current value
$482,429
Previous $505,000
3.37%
% of portfolio
0.48%
Previous 0.5%
Shares
9 transactions
Others Institutions Holding PFE
# of Institutions
3,271Shares Held
3.63BCall Options Held
74.3MPut Options Held
107M-
Vanguard Group Inc Valley Forge, PA516MShares$13.8 Billion0.27% of portfolio
-
Black Rock Inc. New York, NY424MShares$11.3 Billion0.27% of portfolio
-
State Street Corp Boston, MA290MShares$7.76 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA164MShares$4.37 Billion0.85% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA130MShares$3.48 Billion0.73% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $150B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...